"The ability to promote Abilify for use with depression has brought 
its maker (Bristol-Myers Squibb) huge new revenues.  ...
Bristol-Myers spent around $100 million marketing Abilify in 2008. 
Sales of the drug (which costs much more than most anti-depressants) 
reportedly increased approximately 33%."

<http://commonlaw.findlaw.com/2009/08/drug-ads-abilify-fda-approval.html>http://commonlaw.findlaw.com/2009/08/drug-ads-abilify-fda-approval.html 



"People Who experience mood swings, fear, voices and visions"